SPECTRAL AI, INC. Stock-Based Compensation
SPECTRAL AI, INC. (MDAI) reported Stock-Based Compensation of $990.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-11
- SPECTRAL AI, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $807.00K, a 96.35% increase year-over-year.
- SPECTRAL AI, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $183.00K, a 8.50% decline year-over-year.
- SPECTRAL AI, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $243.00K, a 39.66% increase year-over-year.
- SPECTRAL AI, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $261.00K, a 50.87% increase year-over-year.
- SPECTRAL AI, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $1.11M, a 8.04% increase from fiscal 2024.
- SPECTRAL AI, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $1.03M, a 16.98% decline from fiscal 2023.
- SPECTRAL AI, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $1.24M, a 7.62% increase from fiscal 2022.
- SPECTRAL AI, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $1.16M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $807.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $990.00K 10-Q · filed 2026-08-11 | $1.23M derived: sum of 3 quarters · filed 2026-08-11 | $1.49M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $183.00K 10-Q · filed 2026-05-13 | $426.00K derived: sum of 2 quarters · filed 2026-05-13 | $687.00K derived: sum of 3 quarters · filed 2026-05-13 | $1.10M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $243.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $504.00K derived: sum of 2 quarters · filed 2026-03-25 | $915.00K derived: sum of 3 quarters · filed 2026-08-11 | $1.11M 10-K · filed 2026-03-25 |
| 2025-09-30 | $261.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $672.00K derived: sum of 2 quarters · filed 2026-08-11 | $872.00K 10-Q · filed 2025-11-13 | $1.05M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $411.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $611.00K 10-Q · filed 2026-08-11 | $785.00K derived: sum of 3 quarters · filed 2026-08-11 | $958.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $200.00K 10-Q · filed 2026-05-13 | $374.00K derived: sum of 2 quarters · filed 2026-05-13 | $547.00K derived: sum of 3 quarters · filed 2026-05-13 | $949.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $174.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $347.00K derived: sum of 2 quarters · filed 2026-03-25 | $749.00K derived: sum of 3 quarters · filed 2026-03-25 | $1.03M 10-K · filed 2026-03-25 |
| 2024-09-30 | $173.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $575.00K derived: sum of 2 quarters · filed 2025-11-13 | $858.00K 10-Q · filed 2025-11-13 | $1.13M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $402.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $685.00K 10-Q · filed 2025-08-13 | $953.00K derived: sum of 3 quarters · filed 2025-08-13 | $1.23M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $283.00K 10-Q · filed 2025-05-15 | $551.00K derived: sum of 2 quarters · filed 2025-05-15 | $830.00K derived: sum of 3 quarters · filed 2025-05-15 | $1.23M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $268.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $547.00K derived: sum of 2 quarters · filed 2025-03-31 | $943.00K derived: sum of 3 quarters · filed 2025-03-31 | $1.24M 10-K · filed 2025-03-31 |
| 2023-09-30 | $279.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $675.00K derived: sum of 2 quarters · filed 2024-11-06 | $975.00K 10-Q · filed 2024-11-06 | $1.26M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $396.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $696.00K 10-Q · filed 2024-08-12 | $977.00K derived: sum of 3 quarters · filed 2024-08-12 | $1.22M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $300.00K 10-Q · filed 2024-05-09 | $581.00K derived: sum of 2 quarters · filed 2024-05-09 | $828.00K derived: sum of 3 quarters · filed 2024-05-09 | |
| 2022-12-31 | $281.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $528.00K derived: sum of 2 quarters · filed 2024-03-29 | $1.16M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $247.00K derived: 10-Q 9 month − 8-K 6 month · filed 2023-11-14 | $874.00K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $627.00K 8-K · filed 2023-09-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |